首頁 > 市場調查報告書 > 醫療設備

導管泌尿科

市場調查報告書

商品編碼

1917894

泌尿系統護理市場－2026-2031年預測

Urologic Care Market - Forecast from 2026 to 2031

出版日期: 2026年01月08日 | 出版商:

Knowledge Sourcing Intelligence | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計泌尿系統護理市場將從 2025 年的 222.88 億美元成長到 2031 年的 349.56 億美元，複合年成長率為 7.79%。

泌尿系統市場是全球醫療保健領域一個重要且不斷發展的細分市場，致力於預防、診斷和治療影響泌尿系統和男性生殖器官的疾病。市場涵蓋醫療設備、藥品和治療服務，涉及多種疾病，包括腎結石、尿道感染、良性前列腺增生、泌尿系統癌症和尿失禁。在人口趨勢、技術創新和醫療服務模式變革的驅動下，該市場專注於改善臨床療效、提高患者生活品質並簡化泌尿系統手術流程。

推動市場發展的主要強勁動力之一是全球泌尿系統疾病盛行率的上升。這一成長歸因於多種因素，包括人口老化（導致良性前列腺增生和泌尿系統癌症等疾病的發病率升高）、生活方式相關的風險因素以及診斷能力的提高，從而提高了疾病檢出率。腎結石和復發性尿道感染等常見疾病負擔的加重，持續推高了對有效診斷工具、治療方法和長期管理策略的需求，為已開發經濟體和新興經濟體的市場成長奠定了堅實的基礎。

市場技術進步的核心在於微創手術（MIS）技術的廣泛應用和持續改進。腎結石雷射碎石術、機器人輔助根治性攝護腺切除術和內視鏡腫瘤切除術等手術已成為公認的標準治療方案。與傳統開放性手術相比，這些技術具有顯著優勢，包括減輕術後疼痛、縮短住院時間、加快康復速度以及改善美容效果。這種轉變促使並推動了專用設備的創新，包括先進的內視鏡系統、雷射平台、機器人手術主機和一次性器械，從而在整個醫療設備業中催生了一個充滿活力且競爭激烈的細分領域。

隨著手術技術的創新，個人化和精準醫療方法正日益融入泌尿系統實踐。這一趨勢在腫瘤學領域尤其明顯，腫瘤基因組分析被用於指南進行性前列腺癌、膀胱癌和腎癌的治療方案選擇。利用生物標記檢測預測疾病進展以及對特定標靶治療和免疫療法的反應，可以製定更個人化和有效的治療方案。這種個人化醫療的趨勢不僅限於腫瘤學，考慮患者個別因素以最佳化治療效果並最大限度減少副作用的管理策略也正在影響其他疾病領域。

擴大醫療服務覆蓋範圍和採用以病人為中心的照護模式也在重塑市場格局。數位健康技術，尤其是遠端醫療，正被用於遠距諮詢、追蹤護理和慢性病管理，從而改善農村和醫療服務不足地區患者的就醫途徑，並提升所有患者的就醫便利性。此外，人們越來越重視以患者為中心的全面護理，這種護理不僅關注臨床症狀，還關注生活品質問題，例如維持性功能和泌尿功能。這種方法強調跨領域團隊的共同決策，使治療方案更貼近患者的價值觀和偏好。

從地理上看，北美仍然是領先且成熟的市場。這一主導地位得益於泌尿系統疾病的高發病率、完善且技術先進的醫療保健基礎設施、對創新療法有利的報銷政策以及眾多主要企業的集中。該地區強大的臨床研究生態系統也促進了新技術和治療模式在臨床實踐中的快速應用。

競爭格局的特點是既有擁有全面泌尿系統產品組合的大型多元化醫療技術公司，也有專注於結石治療和良性前列腺增生治療等細分領域的專業公司。關鍵的競爭策略圍繞著雷射技術和機器人平台等領域的技術領先地位、將設備與耗材和軟體整合的解決方案的開發，以及證明其卓越療效和成本效益的可靠臨床證據的產生。設備製造商、製藥公司和診斷設備製造商之間的策略聯盟也十分常見，旨在為前列腺癌等複雜疾病打造綜合解決方案。

總之，隨著人口結構變化和技術進步的共同作用，泌尿系統市場持續發展演變。結構性因素支撐著市場成長：全球人口老化和泌尿系統疾病盛行率上升。未來市場發展將受到以下因素的影響：內視鏡設備的進一步小型化和智慧化、機器人平台在常規手術中的應用、人工智慧在診斷影像和治療計劃中的成功應用，以及個人化治療方案的不斷改進。產業相關人員的成功取決於其能否順應微創介入、精準醫療和以病人為中心的醫療服務等整體趨勢進行創新，並在日益注重成本效益的醫療環境中展現自身價值。

本報告的主要優勢：

深入分析：提供對主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分市場。
競爭格局：了解全球主要參與者的策略舉措，並了解透過正確的策略進入市場的機會。
市場促進因素與未來趨勢：探討影響市場的動態因素和關鍵趨勢及其對未來市場發展的影響。
可操作的建議：利用這些見解，在動態環境中做出策略決策，並開拓新的商機和收入來源。
受眾廣泛：適用於Start-Ups、研究機構、顧問公司、中小企業和大型企業，且經濟實惠。

您打算如何使用這份報告？

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

報告範圍：

2021年至2025年的歷史數據和2026年至2031年的預測數據
成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
競爭定位、策略和市場佔有率分析
按業務板塊和地區（包括國家）分類的收入和預測評估
公司概況（策略、產品、財務資訊、關鍵發展等）

介紹
北美洲
- 依產品類型
- 透過使用
- 最終用戶
- 按國家/地區
  - 美國
  - 加拿大
  - 墨西哥
南美洲
- 依產品類型
- 透過使用
- 最終用戶
- 按國家/地區
  - 巴西
  - 阿根廷
  - 其他
歐洲
- 依產品類型
- 透過使用
- 最終用戶
- 按國家/地區
  - 德國
  - 法國
  - 英國
  - 西班牙
  - 義大利
  - 其他
中東和非洲
- 依產品類型
- 透過使用
- 最終用戶
- 按國家/地區
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 其他
亞太地區
- 依產品類型
- 透過使用
- 最終用戶
- 按國家/地區
  - 中國
  - 印度
  - 日本
  - 韓國
  - 印尼
  - 泰國
  - 台灣
  - 其他

第9章競爭格局與分析

主要企業和策略分析
市佔率分析
合併、收購、協議和合作
競爭對手儀錶板

第10章：公司簡介

Fresenius Medical Care AG
Boston Scientific Corporation
Medtronic Plc
Olympus Corporation
Cook Medical Llc
Becton Dickinson
Coloplast Group
Karl Storz
Teleflex Incorporated
Stryker Corporation

第11章附錄

貨幣
先決條件
基準年和預測年時間表
相關人員的主要收益
調查方法
簡稱

簡介目錄

Product Code: KSI061615959

Urologic Care Market is forecasted to rise at a 7.79% CAGR, reaching USD 34.956 billion in 2031 from USD 22.288 billion in 2025.

The urologic care market is a significant and evolving segment of the global healthcare sector, dedicated to the prevention, diagnosis, and management of diseases affecting the urinary system and male reproductive organs. Encompassing medical devices, pharmaceuticals, and therapeutic services, this market addresses a broad range of conditions including kidney stones, urinary tract infections, benign prostatic hyperplasia, urologic cancers, and incontinence. Driven by demographic trends, technological innovation, and a shift in care delivery models, the market is focused on improving clinical outcomes, enhancing patient quality of life, and increasing the efficiency of urologic interventions.

A primary and powerful driver of market evolution is the rising global prevalence of urologic disorders. This increase is attributable to several factors, including aging populations (which elevate the incidence of conditions like prostate enlargement and urologic cancers), lifestyle-related risk factors, and improved diagnostic capabilities leading to higher detection rates. The growing burden of common conditions such as kidney stones and recurrent urinary tract infections creates sustained demand for effective diagnostic tools, treatment modalities, and long-term management strategies, forming a solid foundation for market growth across both developed and emerging economies.

Central to the market's technological advancement is the widespread adoption and continuous refinement of minimally invasive surgical (MIS) techniques. Procedures such as laser lithotripsy for kidney stones, robotic-assisted prostatectomies, and endoscopic tumor resections have become standard of care. These approaches offer demonstrable benefits over traditional open surgery, including reduced postoperative pain, shorter hospital stays, faster recovery, and improved cosmetic outcomes. This shift necessitates and drives innovation in specialized equipment, including advanced endoscopic systems, laser platforms, robotic surgical consoles, and single-use disposable instruments, creating a dynamic and competitive segment within the broader medical device industry.

Parallel to procedural innovation is the increasing integration of personalized and precision medicine approaches into urologic practice. This trend is particularly prominent in oncology, where genomic profiling of tumors guides therapy selection for advanced prostate, bladder, and kidney cancers. The use of biomarker testing to predict disease aggressiveness and response to specific targeted therapies or immunotherapies allows for more tailored and effective treatment plans. This movement toward individualized care extends beyond oncology, influencing management strategies for other conditions by considering patient-specific factors to optimize outcomes and minimize side effects.

The market is also being reshaped by the expansion of healthcare access and the adoption of patient-centric care models. Digital health technologies, particularly telemedicine, are being leveraged to provide remote consultations, follow-up care, and chronic disease management, improving access for patients in rural or underserved areas and enhancing convenience for all. Furthermore, there is a growing emphasis on holistic, patient-focused care that addresses not only the clinical condition but also quality-of-life issues, such as sexual function and continence preservation. This approach involves multidisciplinary teams and shared decision-making, aligning treatment plans more closely with patient values and preferences.

Geographically, North America remains a dominant and mature market. This leadership is supported by a high prevalence of urologic conditions, a well-established and technologically advanced healthcare infrastructure, favorable reimbursement policies for innovative procedures, and a concentration of leading medical device and pharmaceutical companies. The region's robust clinical research ecosystem also facilitates the rapid translation of new technologies and treatment paradigms into clinical practice.

The competitive landscape features large, diversified medical technology corporations with comprehensive urology portfolios, alongside specialized companies focused on niche areas such as stone management or benign prostatic hyperplasia therapy. Key competitive strategies revolve around technological leadership in areas like laser technology and robotic platforms, developing integrated solutions that combine devices with consumables and software, and generating robust clinical evidence to demonstrate superior efficacy and cost-effectiveness. Strategic partnerships between device manufacturers, pharmaceutical companies, and diagnostic firms are also common, aimed at creating comprehensive solutions for complex conditions like prostate cancer.

In conclusion, the urologic care market is advancing through a confluence of demographic necessity and technological progress. Its growth is structurally supported by an aging global population and the increasing burden of urologic disease. Future market development will be shaped by further miniaturization and intelligence of endoscopic devices, the expansion of robotic platforms into more routine procedures, the successful integration of artificial intelligence for diagnostic imaging and procedural planning, and the continued maturation of personalized therapeutic approaches. Success for industry participants will depend on their ability to innovate in alignment with the overarching trends of minimally invasive intervention, precision medicine, and patient-centered care delivery, all while demonstrating value in an increasingly cost-conscious healthcare environment.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2021 to 2025 & forecast data from 2026 to 2031
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Urologic Care Market Segmentation

By Product Type
Implants
Devices & Instruments
Consumables
By Application
Prostate Cancer
Bladder Cancer
Kidney Stones
Erectile Dysfunction
Urinary Incontinence
Others
By End-User
Hospitals
Specialized Clinics & Dialysis Centers
Others
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Italy
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Taiwan
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. UROLOGIC CARE MARKET BY PRODUCT TYPE

5.1. Introduction
5.2. Implants
5.3. Devices & Instruments
5.4. Consumables

6. UROLOGIC CARE MARKET BY APPLICATION

6.1. Introduction
6.2. Prostate Cancer
6.3. Bladder Cancer
6.4. Kidney Stones
6.5. Erectile Dysfunction
6.6. Urinary Incontinence
6.7. Others

7. UROLOGIC CARE MARKET BY END-USER

7.1. Introduction
7.2. Hospitals
7.3. Specialized Clinics & Dialysis Centers
7.4. Others

8. UROLOGIC CARE MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. By Product Type
- 8.2.2. By Application
- 8.2.3. By End-User
- 8.2.4. By Country
  - 8.2.4.1. USA
  - 8.2.4.2. Canada
  - 8.2.4.3. Mexico
8.3. South America
- 8.3.1. By Product Type
- 8.3.2. By Application
- 8.3.3. By End-User
- 8.3.4. By Country
  - 8.3.4.1. Brazil
  - 8.3.4.2. Argentina
  - 8.3.4.3. Others
8.4. Europe
- 8.4.1. By Product Type
- 8.4.2. By Application
- 8.4.3. By End-User
- 8.4.4. By Country
  - 8.4.4.1. Germany
  - 8.4.4.2. France
  - 8.4.4.3. United Kingdom
  - 8.4.4.4. Spain
  - 8.4.4.5. Italy
  - 8.4.4.6. Others
8.5. Middle East and Africa
- 8.5.1. By Product Type
- 8.5.2. By Application
- 8.5.3. By End-User
- 8.5.4. By Country
  - 8.5.4.1. Saudi Arabia
  - 8.5.4.2. UAE
  - 8.5.4.3. Others
8.6. Asia Pacific
- 8.6.1. By Product Type
- 8.6.2. By Application
- 8.6.3. By End-User
- 8.6.4. By Country
  - 8.6.4.1. China
  - 8.6.4.2. India
  - 8.6.4.3. Japan
  - 8.6.4.4. South Korea
  - 8.6.4.5. Indonesia
  - 8.6.4.6. Thailand
  - 8.6.4.7. Taiwan
  - 8.6.4.8. Others